Company news
Minerva Neurosciences, Inc news in 2024
Minerva Neurosciences, Inc's news releases, calls and decks from 2024, newest first.
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
November 4, 2024
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
August 5, 2024
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
April 30, 2024
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
February 26, 2024
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
February 21, 2024